Liothyronine Therapy in Hypothyroidism
DOI:
https://doi.org/10.56260/sciena.v4i5.277Keywords:
Hypothyroidism, liothyronineAbstract
Hypothyroidism is a clinical condition characterized by reduced production of thyroid hormones and is among the most common endocrine disorders, affecting about 3% of the general population, with a higher prevalence in women (5.1%) than in men (0.9%). In Indonesia, the prevalence of hypothyroidism is estimated at 5-10%. Despite achieving normal thyroid stimulating hormone (TSH) levels with levothyroxine (LT4) therapy, many patients continue to experience symptoms like fatigue, depression, and cognitive impairment, which impact their quality of life. A study of 969 hypothyroid patients found that 77.6% were dissatisfied with their treatment and reported low quality of life scores. Although LT4 has been the standard therapy for nearly 50 years due to its stability and the peripheral conversion of thyroxine (T4) to triiodothyronine (T3), recent recommendations from experts in developed countries suggest using liothyronine (LT3) monotherapy or a combination of LT3 and LT4 in selected cases.
References
. Celi FS, Zemskova M, Linderman JD, Smith S, Drinkard B, Sachdev V, et al. Metabolic Effects of Liothyronine Therapy in Hypothyroidism: A Randomized, Double-Blind, Crossover Trial of Liothyronine Versus Levothyroxine. J Clin Endocrinol Metab. 2013;96(11):3466–74.
. Abdullah SS, Lorensia A, Suyanto. Analysis of Real Costs and INA-CBG of Hyperthyroidism in Hasanuddin University Hospital. The Indonesia Journal of Public Health. 2020;16(4):421–9.
. Taylor PN, Eligar V, Muller I, Scholz A, Dayan C, Okosieme O. Combination Thyroid Hormone Replacement; Knowns and Unknowns. Front Endocrinol (Lausanne). 2019;10(706).
. Peterson SJ, Cappola AR, Castro MR, Dayan CM, Farwell AP, Hennessey J V., et al. An Online Survey of Hypothyroid Patients Demonstrates Prominent Dissatisfaction. Thyroid. 2018;28(6):707–21.
. Mitchell AL, Hegedüs L, Žarković M, Hickey JL, Perros P. Patient satisfaction and quality of life in hypothyroidism: An online survey by the british thyroid foundation. Clin Endocrinol (Oxf). 2021;94(3):513–20.
. Heald A, Livingston M, Hughes D. Management of Patients Symptomatically Unresponsive to Levothyroxine: Natural Desiccated Thyroid Extract or the Combination of Levothyroxine and Liothyronine? A Research Priority. Experimental and Clinical Endocrinology & Diabetes. 2020;128(09):596–8.
. Jonklaas J, Bianco AC, Cappola AR, Celi FS, Fliers E, Heuer H, et al. Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document. Thyroid. 2021;31(2):156–82.
. Taylor PN, Razvi S, Muller I, Wass J, Dayan CM, Chatterjee K, et al. Liothyronine cost and prescriptions in England. Lancet Diabetes Endocrinol. 2019;7(1):11–2.
. Chaker L, Razvi S, Bensenor IM, Azizi F, Pearce EN, Peeters RP. Hypothyroidism. Nat Rev Dis Primers. 2022;8(1):30.
. Zamwar UM, Muneshwar KN. Epidemiology, Types, Causes, Clinical Presentation, Diagnosis, and Treatment of Hypothyroidism. Cureus. 2023;15(9):e46241.
. Taylor PN, Albrecht D, Scholz A, Gutierrez-Buey G, Lazarus JH, Dayan CM, et al. Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol. 2018;14(5):301–16.
. Chiovato L, Mariotti S, Magri F. Classification and Etiopathogenesis of Hypothyroidism. In: Vitti P, Hegedüs L, editors. Thyroid Disease. Springer, Cham; 2018. p. 301–31.
. Feldt-Rasmussen U, Effraimidis G, Klose M. The hypothalamus-pituitary-thyroid (HPT)-axis and its role in physiology and pathophysiology of other hypothalamus-pituitary functions. Mol Cell Endocrinol. 2021;525:111173.
. Luongo C, Dentice M, Salvatore D. Deiodinases and their intricate role in thyroid hormone homeostasis. Nat Rev Endocrinol. 2019;15(8):479–88.
. Concepción-Zavaleta MJ, Ildefonso-Najarro SP, Paz-Ibarra JL, Valdivia Fernández-Dávila FR, Deutz Gómez-Condori DC, Rivera-Fabián KE, et al. Liothyronine use in primary hypothyroidism — current concepts. Endokrynol Pol. 2021;72(6):650–60.
. Ortiga‐Carvalho TM, Chiamolera MI, Pazos‐Moura CC, Wondisford FE. Hypothalamus‐Pituitary‐Thyroid Axis. Compr Physiol. 2016;6(3):1387–428.
. Fliers E, Kalsbeek A, Boelen A. Beyond the fixed setpoint of the hypothalamus–pituitary–thyroid axis. Eur J Endocrinol. 2014;171(5):R197–208.
. Aprilia D, Decroli E, Kam A, Tamayo A. Tiroiditis Hashimoto dan Sindroma Gitelman. Majalah Kedokteran Andalas. 2023;46(4):776-787.
. Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. The Lancet. 2017;390(10101):1550–62.
. McAninch EA, Bianco AC. The History and Future of Treatment of Hypothyroidism. Ann Intern Med. 2016;164(1):50.
. Favresse J, Burlacu MC, Maiter D, Gruson D. Interferences With Thyroid Function Immunoassays: Clinical Implications and Detection Algorithm. Endocr Rev. 2018;39(5):830–50.
. Jonklaas J, Razvi S. Reference intervals in the diagnosis of thyroid dysfunction: treating patients not numbers. Lancet Diabetes Endocrinol. 2019;7(6):473–83.
. Brent GA, Koenig RJ. Thyroid and Antithyroid Drugs. In: Brunton LL, Hilal-Dandan R, Knollmann BC, editors. Goodman & GIlman’s The Pharmacological Basis of Therapeutics. 13th ed. McGraw Hill Education; 2018. p. 787–802.
. Idrees T, Palmer S, Maciel RMB, Bianco AC. Liothyronine and Desiccated Thyroid Extract in the Treatment of Hypothyroidism. Thyroid. 2020;30(10):1399–413.
. Jonklaas J, Burman KD. Daily Administration of Short-Acting Liothyronine Is Associated with Significant Triiodothyronine Excursions and Fails to Alter Thyroid-Responsive Parameters. Thyroid. 2016;26(6):770–8.
. Jonklaas J, Burman KD, Wang H, Latham KR. Single-Dose T3 Administration: Kinetics and Effects on Biochemical and Physiologic Parameters. Ther Drug Monit. 2015;37(1):110–8.
. Anderson JL, Jacobs V, May HT, Bair TL, Benowitz BA, Lappe DL, et al. Free thyroxine within the normal reference range predicts risk of atrial fibrillation. J Cardiovasc Electrophysiol. 2020;31(1):18–29.
. Gereben B, McAninch EA, Ribeiro MO, Bianco AC. Scope and limitations of iodothyronine deiodinases in hypothyroidism. Nat Rev Endocrinol. 2015;11(11):642–52.
. Peterson SJ, McAninch EA, Bianco AC. Is a Normal TSH Synonymous With “Euthyroidism” in Levothyroxine Monotherapy? J Clin Endocrinol Metab. 2016;101(12):4964–73.
. Leese GP. Nice guideline on thyroid disease: where does it take us with liothyronine? Thyroid Res. 2020;13(1):7.
. Okosieme O, Gilbert J, Abraham P, Boelaert K, Dayan C, Gurnell M, et al. Management of primary hypothyroidism: statement by the British Thyroid Association Executive Committee. Clin Endocrinol (Oxf). 2016;84(6):799–808.
. Werneck de Castro JP, Fonseca TL, Ueta CB, McAninch EA, Abdalla S, Wittmann G, et al. Differences in hypothalamic type 2 deiodinase ubiquitination explain localized sensitivity to thyroxine. Journal of Clinical Investigation. 2015;125(2):769–81.
. Wiersinga WM. T4 + T3 combination therapy: is there a true effect? Eur J Endocrinol. 2017;177(6):R287–96.
. Fharel, M., Anggraini, D., & Rafli, R. (2024). Deteksi dini gangguan fungsi tiroid pada bayi baru lahir di RSI Siti Rahmah Padang tahun 2023. Jurnal Pengabdian Masyarakat Kesehatan (JURABDIKES), 2(2), 82-86.
. Anggraini, D., & Fharel, M. (2025). Peran Thyroid Stimulating Hormone pada Bayi Baru Lahir. Scientific Journal, 4(1), 23-29.
. Wiersinga WM. T4 + T3 combination therapy: any progress? Endocrine. 2019;66(1):70–8.
. Madan R, Celi FS. Combination Therapy for Hypothyroidism: Rationale, Therapeutic Goals, and Design. Front Endocrinol (Lausanne). 2020;11(371).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Dinda Aprilia, Eva Decroli, Alexander Kam, Settings Jonggara Oktaviandra Siahaan
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
